Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$123.89
-1.6-1.28%
Last update: 12:08 PM
15 minutes delayed
Comments
Loading...
Sarepta Therapeutics (SRPT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Sarepta Therapeutics (NASDAQ:SRPT) Stock Quotes, Forecast and News Summary
Sarepta Therapeutics Stock (NASDAQ: SRPT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Sarepta Therapeutics (SRPT) stock?
You can purchase shares of Sarepta Therapeutics (NASDAQ:SRPT) through any online brokerage.
Who are Sarepta Therapeutics (SRPT) competitors?
Other companies in Sarepta Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Sarepta Therapeutics (SRPT) stock?
Sarepta Therapeutics has a consensus price target of $185.86.
What is the current price for Sarepta Therapeutics (SRPT)?
The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $123.89 last updated September 25, 2024 at 12:08 PM EDT.
Does Sarepta Therapeutics (SRPT) pay a dividend?
There are no upcoming dividends for Sarepta Therapeutics.
When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?
Sarepta Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
Is Sarepta Therapeutics (SRPT) going to split?
There is no upcoming split for Sarepta Therapeutics.
What sector and industry does Sarepta Therapeutics (SRPT) operate in?
Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.